SKI Market

A+| A| A-|

Indian Indices

Sensex

74,243.34 -116.67
( -0.16%)

Global Indices

Nasdaq

51,098.17 -484.76
(-0.94%)

Dow Jones

7,440.28 -165.03
(-2.17%)

Hang Seng

66,711.59 -759.10
(-1.13%)

Nikkei 225

10,374.30 13.98
(0.13%)

Forex

USD-INR

95.73 0.01
(0.01%)

EUR-INR

111.21 0.07
(0.06%)

GBP-INR

128.58 -0.06
(-0.05%)

JPY-INR

0.60 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Kilitch Drugs (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524500

INE729D01010

95.2507628

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KILITCH

18.74

607.28

EPS(TTM)

Face Value()

Div & Yield %

9.27

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	181.59	131.60	117.78	105.16	70.02	60.77
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	181.59	131.60	117.78	105.16	70.02	60.77
Other Income	13.72	6.19	4.60	4.56	4.19	5.71
Stock Adjustments	1.17	0.12	-0.23	0.05	-1.09	0.73
Total Income	196.48	137.91	122.15	109.77	73.12	67.21
EXPENDITURE :
Raw Materials	93.19	66.33	58.27	60.29	37.97	36.49
Power & Fuel Cost	2.61	2.36	2.15	2.00	1.57	1.62
Employee Cost	10.03	7.91	7.47	6.15	5.22	5.65
Other Manufacturing Expenses	5.52	4.69	5.37	5.91	5.48	4.62
Selling & Administrative Expenses	38.03	26.70	23.08	16.48	11.11	11.12
Miscellaneous Expenses	2.25	3.29	3.88	3.25	2.25	0.40
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	151.64	111.29	100.22	94.08	63.59	59.91
Operating Profit	44.83	26.62	21.94	15.69	9.53	7.31
Interest	2.40	2.02	1.15	0.80	0.88	0.93
Gross Profit	42.43	24.60	20.79	14.89	8.65	6.38
Depreciation	1.74	1.24	1.34	0.96	1.14	1.15
Profit Before Tax	40.69	23.36	19.45	13.93	7.51	5.23
Tax	9.85	6.37	4.20	3.63	1.67	0.70
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.32	-0.59	-0.47	-0.23	-0.31	0.07
Reported Net Profit	31.16	17.57	15.72	10.53	6.16	4.46
Extraordinary Items	4.94	1.01	0.77	1.00	0.94	1.55
Adjusted Net Profit	26.22	16.56	14.95	9.53	5.22	2.91
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	131.53	113.96	98.24	87.71	81.56	78.03
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.93
P & L Balance carried down	162.69	131.53	113.96	98.24	87.71	81.56
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	19.37	10.93	10.09	6.76	3.97	2.89
Earnings Per Share(Adj)-Unit Curr	9.48	5.35	4.94	3.31	1.94	1.41
Book Value-Unit Curr	157.28	138.61	122.53	112.65	105.16	98.25
Book Value(Adj)-Unit Curr	76.96	67.82	59.95	55.12	51.46	48.08

74,243.34 -116.67 ( -0.16%)

51,098.17 -484.76 (-0.94%)

7,440.28 -165.03 (-2.17%)

66,711.59 -759.10 (-1.13%)

10,374.30 13.98 (0.13%)

95.73 0.01 (0.01%)

111.21 0.07 (0.06%)

128.58 -0.06 (-0.05%)

0.60 0.00 (0.01%)